Kristian Sass Bak-Jensen;Xujia Zhang;Tina Moeller Tagmose;Jishu Wang;Birgitte Andersen;Helle Fabricius Woeldike;Patrick William Garibay;Henning Thoegersen;Peter Kresten Nielsen
发明人:
Tina Moeller Tagmose,Patrick William Garibay,Xujia Zhang,Henning Thoegersen,Peter Kresten Nielsen,Birgitte Andersen,Jishu Wang,Kristian Sass Bak-Jensen,Helle Fabricius Woeldike
申请号：
US13809273
公开号：
US20130190232A1
申请日:
2011.07.18
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Analogues of FGF21 carrying a modifying, substituted ethylene or benzyl group can be used for treatment or prevention of diabetes, dyslipidemia, obesity, cardiovascular diseases, metabolic syndrome, and/or Non Alcoholic Fatty Liver Disease (NAFLD).
